| Scrip Code | 532540 |
|---|---|
| NSE Symbol | TCS |
| MSEI Symbol | NOTLISTED |
| ISIN | INE467B01029 |
| Name of company | Tata Consultancy Services Limited |
| Type of company | Main Board |
| Class of security | Equity |
| Date of start of financial year | 01-04-2025 |
| Date of end of financial year | 31-03-2026 |
| Date of board meeting when results were approved | 09-04-2026 |
| Date on which prior intimation of the meeting for considering financial results was informed to the exchange | 23-03-2026 |
| Description of presentation currency | INR |
| Level of rounding used in financial results | Lakhs |
| Reporting Type | Quarterly |
| Reporting Quarter | Fourth quarter |
| Nature of report standalone or consolidated | Consolidated |
| Whether results are audited or unaudited for the quarter ended | Audited |
| Whether results are audited or unaudited for the Year to date for current period ended/year ended | Audited |
| Segment Reporting | Multi segment |
| Description of single segment | |
| Start date and time of board meeting | 09-04-2026 11:30:00 |
| End date and time of board meeting | 09-04-2026 15:40:00 |
| Whether cash flow statement is applicable on company | Yes |
| Type of cash flow statement | Cash Flow Indirect |
| Declaration of unmodified opinion or statement on impact of audit qualification | Declaration of unmodified opinion |
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
|---|---|---|---|
| A | Date of start of reporting period | 01-01-2026 | 01-04-2025 |
| B | Date of end of reporting period | 31-03-2026 | 31-03-2026 |
| C | Whether results are audited or unaudited | Audited | Audited |
| D | Nature of report standalone or consolidated | Consolidated | Consolidated |
| 1 | Income | ||
| Revenue from operations | 70,69,800.00 | 2,67,02,100.00 | |
| Other income | 75,700.00 | 4,40,200.00 | |
| Total income | 71,45,500.00 | 2,71,42,300.00 | |
| 2 | Expenses | ||
| (a) | Cost of materials consumed | 0.00 | 0.00 |
| (b) | Purchases of stock-in-trade | 0.00 | 0.00 |
| (c) | Changes in inventories of finished goods, work-in-progress and stock-in-trade | 0.00 | 0.00 |
| (d) | Employee benefit expense | 40,14,300.00 | 1,54,99,400.00 |
| (e) | Finance costs | 26,500.00 | 1,22,700.00 |
| (f) | Depreciation, depletion and amortisation expense | 1,40,600.00 | 5,56,000.00 |
| (f) | Other Expenses | ||
| 1 | Cost of equipment and software licences | 1,44,400.00 | 4,39,900.00 |
| 2 | Other expenses | 9,83,500.00 | 35,23,000.00 |
| Total other expenses | 11,27,900.00 | 39,62,900.00 | |
| Total expenses | 53,09,300.00 | 2,01,41,000.00 | |
| 3 | Total profit before exceptional items and tax | 18,36,200.00 | 70,01,300.00 |
| 4 | Exceptional items | 0.00 | (4,52,600.00) |
| 5 | Total profit before tax | 18,36,200.00 | 65,48,700.00 |
| 6 | Tax expense | ||
| 7 | Current tax | 4,83,200.00 | 16,38,800.00 |
| 8 | Deferred tax | (25,400.00) | (35,500.00) |
| 9 | Total tax expenses | 4,57,800.00 | 16,03,300.00 |
| 10 | Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement | 0.00 | 0.00 |
| 11 | Net Profit Loss for the period from continuing operations | 13,78,400.00 | 49,45,400.00 |
| 12 | Profit (loss) from discontinued operations before tax | 0.00 | 0.00 |
| 13 | Tax expense of discontinued operations | 0.00 | 0.00 |
| 14 | Net profit (loss) from discontinued operation after tax | 0.00 | 0.00 |
| 15 | Share of profit (loss) of associates and joint ventures accounted for using equity method | 0.00 | 0.00 |
| 16 | Total profit (loss) for period | 13,78,400.00 | 49,45,400.00 |
| 17 | Other comprehensive income net of taxes | 66,100.00 | 2,75,000.00 |
| 18 | Total Comprehensive Income for the period | 14,44,500.00 | 52,20,400.00 |
| 19 | Total profit or loss, attributable to | ||
| Profit or loss, attributable to owners of parent | 13,71,800.00 | 49,21,000.00 | |
| Total profit or loss, attributable to non-controlling interests | 6,600.00 | 24,400.00 | |
| 20 | Total Comprehensive income for the period attributable to | ||
| Comprehensive income for the period attributable to owners of parent | 14,35,400.00 | 51,92,100.00 | |
| Total comprehensive income for the period attributable to owners of parent non-controlling interests | 9,100.00 | 28,300.00 | |
| 21 | Details of equity share capital | ||
| Paid-up equity share capital | 36,200.00 | 36,200.00 | |
| Face value of equity share capital | 1 | 1 | |
| 27 | Details of debt securities | ||
| 22 | Reserves excluding revaluation reserve | 1,08,11,600.00 | |
| 23 | Earnings per share | ||
| i | Earnings per equity share for continuing operations | ||
| Basic earnings (loss) per share from continuing operations | 37.92 | 136.01 | |
| Diluted earnings (loss) per share from continuing operations | 37.92 | 136.01 | |
| ii | Earnings per equity share for discontinued operations | ||
| Basic earnings (loss) per share from discontinued operations | 0 | 0 | |
| Diluted earnings (loss) per share from discontinued operations | 0 | 0 | |
| ii | Earnings per equity share | ||
| Basic earnings (loss) per share from continuing and discontinued operations | 37.92 | 136.01 | |
| Diluted earnings (loss) per share from continuing and discontinued operations | 37.92 | 136.01 | |
| 24 | Debt equity ratio | 0 | 0 |
| 25 | Debt service coverage ratio | 0 | 0 |
| 26 | Interest service coverage ratio | 0 | 0 |
| 27 | Disclosure of notes on financial results | ||
| Debt equity ratio | |
|---|---|
| Debt service coverage ratio | |
| Interest service coverage ratio |
| Particulars | Year ended (dd-mm-yyyy) | |
|---|---|---|
| Date of start of reporting period | 01-04-2025 | |
| Date of end of reporting period | 31-03-2026 | |
| Whether results are audited or unaudited | Audited | |
| Nature of report standalone or consolidated | Consolidated | |
| Assets | ||
| 1 | Non-current assets | |
| Property, plant and equipment | 11,03,200.00 | |
| Capital work-in-progress | 2,66,500.00 | |
| Investment property | 0.00 | |
| Goodwill | 9,10,800.00 | |
| Other intangible assets | 11,20,300.00 | |
| Intangible assets under development | 0.00 | |
| Biological assets other than bearer plants | 0.00 | |
| Investments accounted for using equity method | 0.00 | |
| Non-current financial assets | ||
| Non-current investments | 21,800.00 | |
| Trade receivables, non-current | 21,300.00 | |
| Loans, non-current | 77,500.00 | |
| Other non-current financial assets | ||
| 1 | Other financial assets | 2,94,400.00 |
| Total of other non-current financial assets | 2,94,400.00 | |
| Total non-current financial assets | 4,15,000.00 | |
| Deferred tax assets (net) | 4,46,500.00 | |
| Other non-current assets | ||
| 1 | Income tax assets (net) | 1,43,900.00 |
| 2 | Other assets | 2,60,500.00 |
| Total of other non-current assets | 4,04,400.00 | |
| Total non-current assets | 46,66,700.00 | |
| 2 | Current assets | |
| Inventories | 2,900.00 | |
| Current financial asset | ||
| Current investments | 33,77,000.00 | |
| Trade receivables, current | 67,71,400.00 | |
| Cash and cash equivalents | 6,41,700.00 | |
| Bank balance other than cash and cash equivalents | 6,49,100.00 | |
| Loans, current | 1,65,900.00 | |
| Other current financial assets | ||
| Total of other current financial assets | 1,83,300.00 | |
| Total current financial assets | 1,17,88,400.00 | |
| Current tax assets (net) | 1,25,900.00 | |
| Other current assets | ||
| 1 | Other assets | 16,53,300.00 |
| Total of other current assets | 16,53,300.00 | |
| Total current assets | 1,35,70,500.00 | |
| 3 | Non-current assets classified as held for sale | 0.00 |
| 4 | Regulatory deferral account debit balances and related deferred tax Assets | 0.00 |
| Total assets | 1,82,37,200.00 | |
| Equity and liabilities | ||
| 1 | Equity | |
| Equity attributable to owners of parent | ||
| Equity share capital | 36,200.00 | |
| Other equity | 1,06,87,800.00 | |
| Total equity attributable to owners of parent | 1,07,24,000.00 | |
| Non controlling interest | 1,23,800.00 | |
| Total equity | 1,08,47,800.00 | |
| 2 | Liabilities | |
| Non-current liabilities | ||
| Non-current financial liabilities | ||
| Borrowings, non-current | 0.00 | |
| Trade payables, non-current | ||
| (A) Total outstanding dues of micro enterprises and small enterprises | 0.00 | |
| (B) Total outstanding dues of creditors other than micro enterprises and small enterprises | 0.00 | |
| Total Trade payable | 0.00 | |
| Other non-current financial liabilities | ||
| 1 | Class B compulsorily convertible preference shares | 12,600.00 |
| 2 | Lease liabilities | 9,45,300.00 |
| 3 | Other financial liabilities | 58,800.00 |
| Total of other non-current financial liabilities | 10,16,700.00 | |
| Total non-current financial liabilities | 10,16,700.00 | |
| Provisions, non-current | 0.00 | |
| Deferred tax liabilities (net) | 1,20,500.00 | |
| Deferred government grants, Non-current | 0.00 | |
| Other non-current liabilities | ||
| 1 | Employee benefit obligations | 96,100.00 |
| 2 | Unearned and deferred revenue | 64,700.00 |
| Total of other non-current liabilities | 1,60,800.00 | |
| Total non-current liabilities | 12,98,000.00 | |
| Current liabilities | ||
| Current financial liabilities | ||
| Borrowings, current | 0.00 | |
| Trade payables, current | ||
| (A) Total outstanding dues of micro enterprises and small enterprises | 13,600.00 | |
| (B) Total outstanding dues of creditors other than micro enterprises and small enterprises | 14,67,200.00 | |
| Total Trade payable | 14,80,800.00 | |
| Other current financial liabilities | ||
| 1 | Lease liabilities | 1,83,000.00 |
| 2 | Other financial liabilities | 11,19,400.00 |
| Total of other current financial liabilities | 13,02,400.00 | |
| Total current financial liabilities | 27,83,200.00 | |
| Other current liabilities | 16,95,300.00 | |
| 1 | Unearned and deferred revenue | 4,48,700.00 |
| 2 | Other liabilities | 6,86,600.00 |
| 3 | Employee benefit obligations | 5,60,000.00 |
| Total of other current liabilities | 16,95,300.00 | |
| Provisions, current | 1,37,800.00 | |
| Current tax liabilities (Net) | 14,75,100.00 | |
| Deferred government grants, Current | 0.00 | |
| Total current liabilities | 60,91,400.00 | |
| 3 | Liabilities directly associated with assets in disposal group classified as held for sale | 0.00 |
| 4 | Regulatory deferral account credit balances and related deferred tax liability | 0.00 |
| Total liabilities | 73,89,400.00 | |
| Total equity and liabilites | 1,82,37,200.00 | |
| Disclosure of notes on assets and liabilities | ||
| Particulars | 3 months/ 6 month ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |||||
|---|---|---|---|---|---|---|---|
| Date of start of reporting period | 01-01-2026 | 01-04-2025 | |||||
| Date of end of reporting period | 31-03-2026 | 31-03-2026 | |||||
| Whether results are audited or unaudited | Audited | Audited | |||||
| Nature of report standalone or consolidated | Consolidated | Consolidated | |||||
| 1 | Segment Revenue (Income) | ||||||
| (net sale/income from each segment should be disclosed) | |||||||
| 1 | Banking, Financial Services and Insurance | 27,02,100.00 | 1,03,36,300.00 | ||||
| 2 | Manufacturing | 7,00,200.00 | 26,61,400.00 | ||||
| 3 | Consumer Business | 11,34,500.00 | 42,43,200.00 | ||||
| 4 | Communication, Media and Technology | 10,33,400.00 | 39,47,400.00 | ||||
| 5 | Life Sciences and Healthcare | 7,37,100.00 | 27,74,500.00 | ||||
| 6 | Others | 7,62,500.00 | 27,39,300.00 | ||||
| Total Segment Revenue | 70,69,800.00 | 2,67,02,100.00 | |||||
| Less: Inter segment revenue | |||||||
| Revenue from operations | 70,69,800.00 | 2,67,02,100.00 | |||||
| 2 | Segment Result | ||||||
| Profit (+) / Loss (-) before tax and interest from each segment | |||||||
| 1 | Banking, Financial Services and Insurance | 7,11,700.00 | 27,01,100.00 | ||||
| 2 | Manufacturing | 2,12,200.00 | 8,05,100.00 | ||||
| 3 | Consumer Business | 3,33,400.00 | 12,09,000.00 | ||||
| 4 | Communication, Media and Technology | 3,07,200.00 | 11,47,300.00 | ||||
| 5 | Life Sciences and Healthcare | 2,05,600.00 | 7,50,400.00 | ||||
| 6 | Others | 1,57,500.00 | 6,26,900.00 | ||||
| Total Profit before tax | 19,27,600.00 | 72,39,800.00 | |||||
| i. Finance cost | 26,500.00 | 1,22,700.00 | |||||
| ii. Other Unallocable Expenditure net off Unallocable income | 64,900.00 | 5,68,400.00 | |||||
| Profit before tax | 18,36,200.00 | 65,48,700.00 | |||||
| 3 | (Segment Asset - Segment Liabilities) | ||||||
| Segment Asset | |||||||
| 1 | Banking, Financial Services and Insurance | 0.00 | 0.00 | ||||
| 2 | Manufacturing | 0.00 | 0.00 | ||||
| 3 | Consumer Business | 0.00 | 0.00 | ||||
| 4 | Communication, Media and Technology | 0.00 | 0.00 | ||||
| 5 | Life Sciences and Healthcare | 0.00 | 0.00 | ||||
| 6 | Others | 0.00 | 0.00 | ||||
| Total Segment Asset | 0.00 | 0.00 | |||||
| Un-allocable Assets | 0.00 | 0.00 | |||||
| Net Segment Asset | 0.00 | 0.00 | |||||
| 4 | Segment Liabilities | ||||||
| Segment Liabilities | |||||||
| 1 | Banking, Financial Services and Insurance | 0.00 | 0.00 | ||||
| 2 | Manufacturing | 0.00 | 0.00 | ||||
| 3 | Consumer Business | 0.00 | 0.00 | ||||
| 4 | Communication, Media and Technology | 0.00 | 0.00 | ||||
| 5 | Life Sciences and Healthcare | 0.00 | 0.00 | ||||
| 6 | Others | 0.00 | 0.00 | ||||
| Total Segment Liabilities | 0.00 | 0.00 | |||||
| Un-allocable Liabilities | 0.00 | 0.00 | |||||
| Net Segment Liabilities | 0.00 | 0.00 | |||||
| Disclosure of notes on segments | |||||||
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
|---|---|---|---|
| A | Date of start of reporting period | 01-01-2026 | 01-04-2025 |
| B | Date of end of reporting period | 31-03-2026 | 31-03-2026 |
| C | Whether results are audited or unaudited | Audited | Audited |
| D | Nature of report standalone or consolidated | Consolidated | Consolidated |
| Other comprehensive income [Abstract] | |||
| 1 | Amount of items that will not be reclassified to profit and loss | ||
| 1 | Remeasurement of defined employee benefit plans | 19,300.00 | 48,200.00 |
| 2 | Net change in fair values of investments in equity shares carried at fair value through OCI | (7,000.00) | 3,500.00 |
| Total Amount of items that will not be reclassified to profit and loss | 12,300.00 | 51,700.00 | |
| 2 | Income tax relating to items that will not be reclassified to profit or loss | 3,900.00 | 11,400.00 |
| 3 | Amount of items that will be reclassified to profit and loss | ||
| 1 | Net change in fair values of investments other than equity shares carried at fair value through OCI | (75,500.00) | (1,06,600.00) |
| 2 | Net change in intrinsic value of derivatives designated as cash flow hedges | 200.00 | (900.00) |
| 3 | Net change in time value of derivatives designated as cash flow hedges | 700.00 | 0.00 |
| 4 | Exchange differences on translation of financial statements of foreign operations | 1,13,300.00 | 3,14,900.00 |
| Total Amount of items that will be reclassified to profit and loss | 38,700.00 | 2,07,400.00 | |
| 4 | Income tax relating to items that will be reclassified to profit or loss | (19,000.00) | (27,300.00) |
| 5 | Total Other comprehensive income | 66,100.00 | 2,75,000.00 |
| Particulars | Year ended (dd-mm-yyyy) | |||||
|---|---|---|---|---|---|---|
| A | Date of start of reporting period | 01-04-2025 | ||||
| B | Date of end of reporting period | 31-03-2026 | ||||
| C | Whether results are audited or unaudited | Audited | ||||
| D | Nature of report standalone or consolidated | Consolidated | ||||
| Statement of cash flows | ||||||
| Cash flows from used in operating activities | ||||||
| Profit before tax | 65,48,700.00 | |||||
| Adjustments for reconcile profit (loss) | ||||||
| Adjustments for finance costs | 1,22,700.00 | |||||
| Adjustments for decrease (increase) in inventories | (800.00) | |||||
| Adjustments for decrease (increase) in trade receivables, current | (5,24,800.00) | |||||
| Adjustments for decrease (increase) in trade receivables, non-current | 0.00 | |||||
| Adjustments for decrease (increase) in other current assets | 83,700.00 | |||||
| Adjustments for decrease (increase) in other non-current assets | 0.00 | |||||
| Adjustments for other financial assets, non-current | 0.00 | |||||
| Adjustments for other financial assets, current | 19,700.00 | |||||
| Adjustments for other bank balances | 0.00 | |||||
| Adjustments for increase (decrease) in trade payables, current | (1,10,500.00) | |||||
| Adjustments for increase (decrease) in trade payables, non-current | 0.00 | |||||
| Adjustments for increase (decrease) in other current liabilities | 30,300.00 | |||||
| Adjustments for increase (decrease) in other non-current liabilities | 0.00 | |||||
| Adjustments for depreciation and amortisation expense | 5,56,000.00 | |||||
| Adjustments for impairment loss reversal of impairment loss recognised in profit or loss | 0.00 | |||||
| Adjustments for provisions, current | 0.00 | |||||
| Adjustments for provisions, non-current | 0.00 | |||||
| Adjustments for other financial liabilities, current | 2,81,400.00 | |||||
| Adjustments for other financial liabilities, non-current | 0.00 | |||||
| Adjustments for unrealised foreign exchange losses gains | (17,600.00) | |||||
| Adjustments for dividend income | 0.00 | |||||
| Adjustments for interest income | 0.00 | |||||
| Adjustments for share-based payments | 0.00 | |||||
| Adjustments for fair value losses (gains) | 0.00 | |||||
| Adjustments for undistributed profits of associates | 0.00 | |||||
| Other adjustments for which cash effects are investing or financing cash flow | (71,800.00) | |||||
| Other adjustments to reconcile profit (loss) | 100.00 | |||||
| Other adjustments for non-cash items | 1,19,600.00 | |||||
| Share of profit and loss from partnership firm or association of persons or limited liability partnerships | 0.00 | |||||
| Total adjustments for reconcile profit (loss) | 4,88,000.00 | |||||
| Net cash flows from (used in) operations | 70,36,700.00 | |||||
| Dividends received | (3,500.00) | |||||
| Interest paid | 0.00 | |||||
| Interest received | (3,85,400.00) | |||||
| Income taxes paid (refund) | 14,38,400.00 | |||||
| Other inflows (outflows) of cash | 0.00 | |||||
| Net cash flows from (used in) operating activities | 52,09,400.00 | |||||
| Cash flows from used in investing activities | ||||||
| Cash flows from losing control of subsidiaries or other businesses | 0.00 | |||||
| Cash flows used in obtaining control of subsidiaries or other businesses | 7,30,400.00 | |||||
| Other cash receipts from sales of equity or debt instruments of other entities | 0.00 | |||||
| Other cash payments to acquire equity or debt instruments of other entities | 0.00 | |||||
| Other cash receipts from sales of interests in joint ventures | 0.00 | |||||
| Other cash payments to acquire interests in joint ventures | 0.00 | |||||
| Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships | 0.00 | |||||
| Cash payment for investment in partnership firm or association of persons or limited liability partnerships | 0.00 | |||||
| Proceeds from sales of property, plant and equipment | 6,500.00 | |||||
| Purchase of property, plant and equipment | 3,67,000.00 | |||||
| Proceeds from sales of investment property | 0.00 | |||||
| Purchase of investment property | 0.00 | |||||
| Proceeds from sales of intangible assets | 4,100.00 | |||||
| Purchase of intangible assets | 40,800.00 | |||||
| Proceeds from sales of intangible assets under development | 0.00 | |||||
| Purchase of intangible assets under development | 0.00 | |||||
| Proceeds from sales of goodwill | 0.00 | |||||
| Purchase of goodwill | 0.00 | |||||
| Proceeds from biological assets other than bearer plants | 0.00 | |||||
| Purchase of biological assets other than bearer plants | 0.00 | |||||
| Proceeds from government grants | 0.00 | |||||
| Proceeds from sales of other long-term assets | 0.00 | |||||
| Purchase of other long-term assets | 0.00 | |||||
| Cash advances and loans made to other parties | 0.00 | |||||
| Cash receipts from repayment of advances and loans made to other parties | 0.00 | |||||
| Cash payments for future contracts, forward contracts, option contracts and swap contracts | 0.00 | |||||
| Cash receipts from future contracts, forward contracts, option contracts and swap contracts | 0.00 | |||||
| Dividends received | 3,00,800.00 | |||||
| Interest received | 8,400.00 | |||||
| Income taxes paid (refund) | 0.00 | |||||
| Other inflows (outflows) of cash | (4,66,100.00) | |||||
| Net cash flows from (used in) investing activities | (12,84,500.00) | |||||
| Cash flows from used in financing activities | ||||||
| Proceeds from changes in ownership interests in subsidiaries | 0.00 | |||||
| Payments from changes in ownership interests in subsidiaries | 0.00 | |||||
| Proceeds from issuing shares | 20,000.00 | |||||
| Proceeds from issuing other equity instruments | 0.00 | |||||
| Payments to acquire or redeem entity's shares | 0.00 | |||||
| Payments of other equity instruments | 0.00 | |||||
| Proceeds from exercise of stock options | 0.00 | |||||
| Proceeds from issuing debentures notes bonds etc | 0.00 | |||||
| Proceeds from borrowings | 0.00 | |||||
| Repayments of borrowings | 0.00 | |||||
| Payments of lease liabilities | 1,86,100.00 | |||||
| Dividends paid | 39,57,100.00 | |||||
| Interest paid | 90,100.00 | |||||
| Income taxes paid (refund) | 0.00 | |||||
| Other inflows (outflows) of cash | 0.00 | |||||
| Net cash flows from (used in) financing activities | (42,13,300.00) | |||||
| Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes | (2,88,400.00) | |||||
| Effect of exchange rate changes on cash and cash equivalents | ||||||
| Effect of exchange rate changes on cash and cash equivalents | 95,900.00 | |||||
| Net increase (decrease) in cash and cash equivalents | (1,92,500.00) | |||||
| Cash and cash equivalents cash flow statement at beginning of period | 8,34,200.00 | |||||
| Cash and cash equivalents cash flow statement at end of period | 6,41,700.00 | |||||
| Whether results are audited or unaudited | Audited |
|---|---|
| Declaration of unmodified opinion or statement on impact of audit qualification | Declaration of unmodified opinion |
| Auditor's opinion | |
| Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results | Yes |
| Sr No. | Audit firm's name | Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI | Certificate valid upto | ||
| 1 | BSR and Co LLP | Yes | 31-07-2028 | ||
|---|---|---|---|---|---|